A quantitative rabbit model of vaccinia keratitis

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 9, 2010, Pages 4531-4540

  Altmann, Sharon ^a   Emanue, Andrew ^b   Toomey, Megan ^a   McIntyre, Kim ^a   Covert, Jill ^a,c   Dubielzig, Richard Redd ^a   Leatherberry, Gary ^a   Murphy, Christopher J ^a,c,d   Kodihalli, Shantha ^b   Brandt, Curtis R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Cangene Corporation   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VACCINIA VIRUS ANTIBODY; VIRUS ANTIBODY; SMALLPOX VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BODY WEIGHT; CHEMOSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VACCINIA; VACCINIA KERATITIS; VACCINIA VIRUS; VIRUS KERATITIS; VIRUS STRAIN; ANIMAL; BLOOD; CERCOPITHECUS; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; HOSPITALIZATION; IMMUNOLOGY; KERATITIS; LIP; PATHOPHYSIOLOGY; RABBIT; SKIN ULCER; VERO CELL; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; BODY WEIGHT; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; FEMALE; KERATITIS; LIP; RABBITS; SEVERITY OF ILLNESS INDEX; SKIN ULCER; SMALLPOX VACCINE; VACCINIA; VACCINIA VIRUS; VERO CELLS;

EID: 77957331966     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5106     Document Type: Article

References (39)

1. CDC. Public Health Service recommendation on smallpox vaccination. MMWR. 1971;20:339-345.
2. WHO. Declaration of global eradication of smallpox. Weekly Epidemiol Rec. 1980;55:148.
3. Baggs J, Chen RT, Damon IK, et al. Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program. Clin Infect Dis. 2005;40:1133-1140.
4. Casey CG, Iskander JK, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA. 2005;294:2734-2743.
5. CDC. Adverse reaction to smallpox vaccine. Commun Dis Rep CDR Wkly. 1994;4:157.
6. CDC. Update. adverse events following civilian smallpox vaccination: United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:475-477.
7. CDC. Update. cardiac-related events during the civilian smallpox vaccination program: United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:492-496.
8. Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Smallpox vaccination: a review, part II. Adverse events. Clin Infect Dis. 2003;37:251-271.
9. Pepose JS, Margolis TP, LaRussa P, Pavan-Langston D. Ocular complications of smallpox vaccination. Am J Ophthalmol. 2003;136: 343-352.
10. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346:1265-1274.
11. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med. 1969;281:1201-1208.
12. Duke-Elder S. Diseases of the Outer Eye. St. Louis: CV Mosby Co.; 1965.
13. Ruben FL, Lane JM. Ocular vaccinia: an epidemiologic analysis of 348 cases. Arch Ophthalmol. 1970;84:45-48.
14. Darrell RW, Vrabec F. Vaccinia virus infection of the rabbit cornea. Arch Ophthalmol. 1971;86:568-574.
15. Matas BR, Dawson CR, Togni B. Vaccinia-infected rabbit cornea: a transmission electron microscopic study. Invest Ophthalmol. 1973;12:782-786.
16. Matas BR, Spencer WH, Hayes TL, Dawson CR. Morphology of experimental vaccinial superficial punctate keratitis: a scanning and transmission electron microscopic study. Invest Ophthalmol. 1971;10:348-356
17. Speakman JS, Ormsby HL. Studies of immunity in vaccinia keratitis in rabbits. Am J Ophthalmol. 1955;40:194-200
18. Casazza AM, Ghione M. Therapeutic action of distamycin A on Vaccinia virus infections in vivo. Chemotherapia. 1964;9:80-87.
19. Fulginiti VA, Winograd LA, Jackson M, Ellis P. Therapy of experimental vaccinal keratitis: effect of idoxuridine and VIG. Arch Ophthalmol. 1965;74:539-544.
20. Hyndiuk RA, Okumoto M, Damiano RA, Valenton M, Smolin G. Treatment of vaccinial keratitis with vidaribine. Arch Ophthalmol. 1976;94:1363-1364.
21. Hyndiuk RA, Seideman S, Leibsohn JM. Treatment of vaccinial keratitis with trifluorothymidine. Arch Ophthalmol. 1976;94: 1785-1786.
22. Jones BR, Galbraith JE, Al-Hussaini MK. Vaccinial keratitis treated with interferon. Lancet. 1962;1:875-879.
23. Kaufman HL, Nesburn AB, Maloney ED. Cure of Vaccinia infection by 5-iodo-2-deoxyuridine. Virology. 1962;18:567-569.
24. Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions. Guidance for clinicians. MMWR Recomm Rep. 2003;52: 1-28.
25. Altmann SE, Jones JC, Schultz-Cherry S, Brandt CR. Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide. Virology. 2009;388:248-259.
26. Athanasiu P, Anghelescu S, Predescu E, et al. Rapid detection by immunofluorescence of multiple viral infections in patients with keratitis. Virologie. 1984;35:83-88.
27. Belongia EA, Naleway AL. Smallpox vaccine: the good, the bad, and the ugly. Clin Med Res. 2003;1:87-92.
28. Doggart JH. Herpes zoster ophthalmicus. Br J Ophthalmol. 1933; 17:513-524.
29. Doggart JH. Superficial punctate keratitis. Br J Ophthalmol. 1933; 17:65-82.
30. Dominguez-Berjon MF, Hernando-Briongos P, Miguel-Arroyo PJ, Echevarria JE, Casas I. Adenovirus transmission in a nursing home: analysis of an epidemic outbreak of keratoconjunctivitis. Gerontology. 2007;53:250-254.
31. Lalitha P, Rathinam S, Banushree K, Maheshkumar S, Vijayakumar R, Sathe P. Ocular involvement associated with an epidemic outbreak of Chikungunya virus infection. Am J Ophthalmol. 2007; 144:552-556.
32. Thomas PA, Geraldine P. Infectious keratitis. Curr Opin Infect Dis. 2007;20:129-141.
33. Rennie AG, Cant JS, Foulds WS, Pennington TH, Timbury MC. Ocular vaccinia. Lancet. 1974;2:273-275.
34. Semba RD. The ocular complications of smallpox and smallpox immunization. Arch Ophthalmol. 2003;121:715-719.
35. Brandt CR. The role of viral and host genes in corneal infection with herpes simplex virus type 1. Exp Eye Res. 2005;80:607-621.
36. Belshe RB, Newman FK, Frey SE, et al. Dose-dependent neutralizing- antibody responses to vaccinia. J Infect Dis. 2004;189:493-497.
37. Chaudhri G, Panchanathan V, Bluethmann H, Karupiah G. Obligatory requirement for antibody in recovery from a primary poxvirus infection. J Virol. 2006;80:6339-6344.
38. Xu R, Johnson AJ, Liggitt D, Bevan MJ. Cellular and humoral immunity against Vaccinia virus infection of mice. J Immunol. 2004;172:6265-6271.
39. Mack TM, Noble J Jr, Thomas DB. A prospective study of serum antibody and protection against smallpox. Am J Trop Med Hyg. 1972;21:214-218.